Cite
HARVARD Citation
Hézode, C. et al. (2017). Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral–Experienced Patients With Hepatitis C. Clinical infectious diseases. pp. 1615-1618. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hézode, C. et al. (2017). Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral–Experienced Patients With Hepatitis C. Clinical infectious diseases. pp. 1615-1618. [Online].